(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 15.45% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.81%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.61%.
Si Bone's revenue in 2026 is $200,925,000.On average, 11 Wall Street analysts forecast SIBN's revenue for 2026 to be $10,378,400,792, with the lowest SIBN revenue forecast at $9,933,214,699, and the highest SIBN revenue forecast at $10,749,389,203. On average, 11 Wall Street analysts forecast SIBN's revenue for 2027 to be $11,927,719,060, with the lowest SIBN revenue forecast at $11,316,913,141, and the highest SIBN revenue forecast at $12,415,745,481.
In 2028, SIBN is forecast to generate $13,755,720,289 in revenue, with the lowest revenue forecast at $13,214,253,870 and the highest revenue forecast at $14,162,482,582.